Related Experiment Videos
[Iatrogenic diffuse interstitial pneumonia linked to 5-aminosalicylate]
D Declerck1, B Wallaert, G Demarcq-Delerue
1Service de Pneumologie et d'Immunologie-allergologie, Hôpital A.-Calmette, Lille.
Revue Des Maladies Respiratoires
|January 1, 1994
Summary
This case study highlights a rare drug-induced pneumonia caused by 5-aminosalicylate (Pentasa). The patient recovered after discontinuing Pentasa, suggesting it was the cause of the interstitial lung disease.
Area of Science:
- Pulmonology
- Gastroenterology
- Pharmacology
Background:
- Iatrogenic pneumonias are uncommon complications of sulphasalazine treatment.
- 5-aminosalicylate (Pentasa) is used for inflammatory bowel diseases like ulcerative colitis.